• LAST PRICE
    0.0349
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0160/ 100
  • Ask / Lots
    0.1058/ 50
  • Open / Previous Close
    --- / 0.0349
  • Day Range
    ---
  • 52 Week Range
    Low 0.0344
    High 0.2981
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Oct 29, 2024

  • Oct 25, 2024

      Show headlines and story abstract
    • 7:02PM ET on Friday Oct 25, 2024 by Newsfile
      Companies Mentioned: BAUFF

      Vancouver, British Columbia--(Newsfile Corp. - October 25, 2024) - Blue Star Gold Corp. (TSXV: BAU) (OTCQB: BAUFF) (FSE: 5WP0) ("Blue Star" or the "Company") announces that, further to its news release of October 25, 2023, it has issued 98,451 common shares (the "Shares") at a deemed price of $0.45 per Share which represents the second tranche of Shares owing pursuant to a renewal agreement (the "Agreement") entered into with Dr. Georg Pollert, a director of the Company and a controlling shareholder, in relation with a loan in the principal amount of $2,537,434 (the "Loan"), being $2,435,542 as original principal and $101,892.40 as accrued interest. The Loan has a term of three years and bears interest at 3% per annum.

    • 7:02PM ET on Friday Oct 25, 2024 by Dow Jones
      Companies Mentioned: BAU

      Vancouver, British Columbia--(Newsfile Corp. - October 25, 2024) - Blue Star Gold Corp. (TSXV: BAU) (OTCQB: BAUFF) (FSE: 5WP0) ("Blue Star" or the "Company") announces that, further to its news release of October 25, 2023, it has issued 98,451 common shares (the "Shares") at a deemed price of $0.45 per Share which represents the second tranche of Shares owing pursuant to a renewal agreement (the "Agreement") entered into with Dr. Georg Pollert, a director of the Company and a controlling shareholder, in relation with a loan in the principal amount of $2,537,434 (the "Loan"), being $2,435,542 as original principal and $101,892.40 as accrued interest. The Loan has a term of three years and bears interest at 3% per annum.

Peers Headlines

No documents available